Skip to main content
DIAN DIAGNOSTICS GROUP CO.,LTD. logo

DIAN DIAGNOSTICS GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 300244 ISIN · CNE1000015N1 LEI · 3003006MMJLCVIIKTA82 Shenzhen Stock Exchange Human health and social work activities
Open in API
Filings indexed 2,161 across all filing types
Latest filing 2024-06-27 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300244

About DIAN DIAGNOSTICS GROUP CO.,LTD.

https://www.dazd.cn

DIAN Diagnostics Group Co., Ltd. is a comprehensive medical diagnostic service provider specializing in the independent clinical laboratory (ICL) sector. The company operates through an integrated "Service + Product" business model, offering a wide range of diagnostic services including clinical testing, pathology, forensic identification, and genomic testing. It manages an extensive network of diagnostic laboratories and provides outsourced testing services to medical institutions. In addition to laboratory services, the group distributes in vitro diagnostic (IVD) instruments and reagents from global and domestic manufacturers. Its technical capabilities span molecular diagnostics, mass spectrometry, and digital pathology, supporting precision medicine and public health initiatives. The company serves hospitals, community health centers, and research institutions, focusing on enhancing diagnostic efficiency and clinical decision-making through advanced technology.

Recent filings

Filing Released Lang Actions
关于变更回购股份用途并注销的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company regarding the change in the purpose of shares repurchased and their subsequent cancellation, including details about the share repurchase plan, the number of shares involved, and the impact on the company's capital structure. It is not a financial report, earnings release, or management discussion, but rather a formal disclosure about share repurchase and capital reduction. This fits the category of Transaction in Own Shares (POS), which covers announcements about the company buying back or selling its own shares, including share repurchase and cancellation.
2024-06-27 Chinese
公司章程（2024年6月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 迪安诊断技术集团股份有限公司 dated June 2024. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance matters. It references relevant laws such as the Company Law and Securities Law of China. The content is a comprehensive governance document that sets out the internal rules and structure of the company rather than financial results, audit opinions, or announcements. It is not a report of financial performance, nor an announcement or transcript. It is a governance document detailing the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the actual governance document, not a mere announcement or summary.
2024-06-27 Chinese
关于回购公司股份比例达到1%的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan, detailing the number of shares repurchased, the percentage of total shares, prices, and compliance with regulatory requirements. It references the company's board approval of the repurchase plan and provides updates on the repurchase activity. The document is short (1278 characters) and focuses on the share buyback activity rather than financial results or other report types. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buying back or selling its own shares.
2024-06-24 Chinese
关于控股股东部分股份质押续期的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the renewal of a pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the pledge period, and assurances about the financial and operational impact of the pledge. There is no financial statement, no management discussion of results, no earnings data, and no mention of a report being attached or published. The document is a regulatory announcement about share pledge renewal, which relates to capital structure but is not a financing update involving new capital or fundraising. It is not a report or presentation but a formal disclosure of share pledge status. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-06-21 Chinese
关于2023年年度权益分派实施后调整回购股份价格上限的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from a company regarding the adjustment of the upper limit of the share repurchase price following the implementation of the 2023 annual dividend distribution. It details the share repurchase plan, the dividend distribution, and the resulting adjustment to the repurchase price limit. The document is short (1374 characters) and focuses on share repurchase price adjustments and dividend distribution details, not a full financial report or earnings release. It is not a report itself but an announcement about share repurchase and dividend-related adjustments. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers company announcements about share buybacks or sales of own shares.
2024-06-12 Chinese
2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2023 annual equity distribution (dividend) by the company, including details on dividend amount, record date, ex-dividend date, and related shareholder meeting approvals. It does not contain full financial statements or comprehensive financial performance data. The document is relatively short (2349 characters) and focuses on dividend distribution details rather than presenting a full annual report or interim report. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2024-06-05 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.